IDXX Stock Overview
Develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$471.90 |
| 52 Week High | US$548.88 |
| 52 Week Low | US$356.14 |
| Beta | 1.5 |
| 1 Month Change | 19.85% |
| 3 Month Change | 0.61% |
| 1 Year Change | -1.81% |
| 3 Year Change | 28.71% |
| 5 Year Change | 63.91% |
| Change since IPO | 49,820.03% |
Recent News & Updates
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why
May 01
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value?
Apr 24IDEXX Laboratories: I Love The Business, Not The Stock Price
Apr 14Recent updates
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why
May 01Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value?
Apr 24IDEXX Laboratories: I Love The Business, Not The Stock Price
Apr 14We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
Mar 30IDEXX Laboratories: A Top Dog In The Pet Care Market
Mar 12IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Business Is Yet to Catch Up With Its Share Price
Feb 27IDEXX Laboratories And Its Real Value
Feb 10Calculating The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Jan 13IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Dec 26At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?
Nov 19IDEXX Laboratories Q3: Weak End-Market Demand Continues
Nov 11Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects
Oct 28Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 15We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
Sep 18A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Sep 05What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?
Aug 20
Global Expansion And Innovative Products Propel Revenue And Margin Growth Amidst Challenges
Aug 19 IDEXX's international and innovative product growth, like the inVue Dx Cellular Analyzer, fuels potential revenue and market share increases globally.IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits
Aug 12A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital
Jul 02Looking For Fast Growth In Healthcare? IDEXX Has You Covered
Jun 28Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jun 04Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?
May 21IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
Apr 08IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified
Jan 16Shareholder Returns
| IDXX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.9% | 1.5% | 3.0% |
| 1Y | -1.8% | 8.1% | 10.1% |
Return vs Industry: IDXX underperformed the US Medical Equipment industry which returned 8.1% over the past year.
Return vs Market: IDXX underperformed the US Market which returned 10.1% over the past year.
Price Volatility
| IDXX volatility | |
|---|---|
| IDXX Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: IDXX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: IDXX's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits.
IDEXX Laboratories, Inc. Fundamentals Summary
| IDXX fundamental statistics | |
|---|---|
| Market cap | US$37.95b |
| Earnings (TTM) | US$894.97m |
| Revenue (TTM) | US$3.93b |
42.4x
P/E Ratio9.7x
P/S RatioIs IDXX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDXX income statement (TTM) | |
|---|---|
| Revenue | US$3.93b |
| Cost of Revenue | US$1.52b |
| Gross Profit | US$2.41b |
| Other Expenses | US$1.51b |
| Earnings | US$894.97m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.13 |
| Gross Margin | 61.28% |
| Net Profit Margin | 22.76% |
| Debt/Equity Ratio | 64.9% |
How did IDXX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/04 13:26 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IDEXX Laboratories, Inc. is covered by 29 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Ishan Majumdar | Baptista Research |
| Navann Ty Dietschi | BNP Paribas Exane |